Danske Bank’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Buy
132,217
+3,600
+3% +$316K 0.02% 434
2026
Q1
$11.6M Sell
128,617
-5,100
-4% -$468K 0.03% 403
2025
Q4
$12M Buy
133,717
+7,400
+6% +$702K 0.03% 408
2025
Q3
$12.4M Buy
126,317
+2,300
+2% +$228K 0.03% 381
2025
Q2
$11.3M Buy
124,017
+8,604
+7% +$832K 0.03% 413
2025
Q1
$13.1M Sell
115,413
-19,224
-14% -$2.06M 0.04% 347
2024
Q4
$14.2M Buy
134,637
+30,524
+29% +$3.28M 0.04% 345
2024
Q3
$11.2M Sell
104,113
-31,069
-23% -$3.39M 0.04% 367
2024
Q2
$14.7M Buy
135,182
+27,469
+26% +$3.24M 0.05% 294
2024
Q1
$14.2M Buy
+107,713
New +$13.5M 0.04% 351

Other funds holding ZBH

Danske Bank's ZBH Position: Q2 2026 in Review

Danske Bank increased its Zimmer Biomet (ZBH) stake by 2.8% in Q2 2026, buying an estimated $316K and bringing the position to 132,217 shares worth $11.4M. The position accounts for 0.02% of the portfolio, ranked #434.

Danske Bank first reported a position in ZBH in Q1 2024 and has held it in 10 quarters since. The position peaked at $14.7M in Q2 2024. 911 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Danske Bank held 132,217 shares of Zimmer Biomet worth $11.4M as of Q2 2026.
  • Danske Bank bought 3,600 Zimmer Biomet shares in Q2 2026, an estimated $316K.
  • Zimmer Biomet made up 0.02% of Danske Bank's portfolio in Q2 2026, its #434 holding.
  • Danske Bank first reported a position in Zimmer Biomet in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Zimmer Biomet position peaked at $14.7M in Q2 2024.
  • 911 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.